Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Download the PDF here. This post appeared first on investingnews.com Prev Post Widespread Natural Rutile Observed Throughout the Central Rutile Tenement Package June 11, 2025 Next Post Micron’s Coiled for An Explosive Move (Up or Down): Here’s What You Need to Know Now June 11, 2025 Related Posts Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases June 12, 2025 Nuclear Fuels Commences 2025 Kaycee Uranium Project Drill Program June 12, 2025 Juggernaut Exploration: Advancing High-grade Precious Metals Assets in Northern BC’s Golden Triangle June 12, 2025
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases June 12, 2025
Juggernaut Exploration: Advancing High-grade Precious Metals Assets in Northern BC’s Golden Triangle June 12, 2025